Evidence map›Paper›PMID 41535092›Full record

ArticleArchives of disease in childhood2026

Analysis of infectious complications in paediatric autoimmune neutropenia: a French nationwide retrospective cohort study.

Robin Dhersin, Estelle Trebucq, Marie Rimbert, Jérémie Rouger-Gaudichon, Florent Neumann, Pascal Chastagner, Grégory Guimard, Dominique Plantaz, Sandrine Billet, Wadih Abouchahla and 21 more

Abstract readMulticenter Study
In one paragraph

Article in Archives of disease in childhood, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Robin Dhersin *Infectious Diseases and Tropical Medicine, Angers University Hospital, Angers, France.
Estelle Trebucq *Oncology, Hematology, Immunology Pediatric Unit, Angers University Hospital, Angers, France.
Marie RimbertImmunology Biology, University Hospital Centre Nantes, Nantes, France.
Jérémie Rouger-GaudichonPediatric Oncology and Hematology Department, CHU Caen, Caen, France.ORCID 0000-0001-6448-8832
Florent NeumannPediatric Department, University Hospital Centre Dijon General Hospital, Dijon, France.
Pascal ChastagnerDepartment of Pediatric Oncology, Nancy University Hospital Center, Nancy, France.
Grégory GuimardDepartment of Paediatric Oncology, University Hospital Centre Reims, Reims, France.
Dominique PlantazPédiatrie générale multidisciplinaire, CHU Grenoble, Grenoble, France.
Sandrine BilletDepartment of Pediatric Onco-Immuno-Hematology, CHU Grenoble Alpes, Grenoble, France.
Wadih AbouchahlaPediatric Hematology Department, Lille University Hospital, Lille, France.
Audrey PetitPediatric Haematology Department, Timone Enfant, APHM, Marseille, France.
Eric JeziorskiPédiatrie générale, CHRU Montpellier, Montpellier, France.
Valérie Li Thiao TeDepartment of Paediatric Haematology/Oncology, Amiens-Picardy University Hospital, Amiens, France.
Nathalie CheikhDepartment of Pediatrics, Centre Hospitalier Universitaire de Besancon, Besançon, France.
Nathalie AladjidiPediatric Department; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE), University Hospital Centre Bordeaux, Talence, France.
Liana CarausuDepartment of Pediatric Hematology-Oncology, Brest University Hospital Centre, Brest, France.
Caroline ThomasPediatric Hematology, Centre Hospitalier Universitaire de Nantes, Nantes, France.ORCID 0000-0002-3939-9317
Audrey GrainDepartment of Hemato-Oncology Pediatric, University Hospital Centre Nantes, Nantes, France.
Joy BenadibaUniversity Hospital Centre Nice, Nice, France.
Laurence BlancPaediatric Haematology-Oncology Unit, University Hospital Centre Poitiers, Poitiers, France.
Elie CousinDepartment of Hemato-Oncology Pediatric, Rennes University Hospital, Rennes, France.
Aude Marie-CardinePediatric Immuno-Hematology-Oncology Unit, University Hospital Centre Rouen Charles-Nicolle Site, Rouen, France.
Despina MoshousDepartment of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospitals, Paris, France.
Marlène PasquetDepartment of Hemato-Oncology Pediatric, Toulouse III University-Paul Sabatier Purpan Faculty of Medicine, Toulouse, France.
Julien LejeuneDepartment of Pediatric Hematology-Oncology, Hôpital Gatien de Clocheville, Tours, France.
Saba AzarnoushDepartment of Pediatric Immuno-Hematology, Robert-Debré Mother-Child University Hospital, Paris, France.
Blandine BeaupainCentre de référence des neutropénies chroniques, Registre des neutropénies chroniques, Armand-Trousseau Hospital, Paris, France.
Vincent DubéeInfectious Diseases and Tropical Medicine, Angers University Hospital, Angers, France.
Isabelle PellierOncology, Hematology, Immunology Pediatric Unit, Angers University Hospital, Angers, France.
Jean DonadieuCentre de référence des neutropénies chroniques, Registre des neutropénies chroniques, Armand-Trousseau Hospital, Paris, France.
Coralie MallebrancheOncology, Hematology, Immunology Pediatric Unit, Angers University Hospital, Angers, France coralie.mallebranche@chu-angers.fr.ORCID 0000-0002-8385-4057

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutoimmune neutropenia (AIN) is the main cause of chronic neutropenia in children, but its infectious consequences remain poorly studied. The primary objective of this study was to evaluate infectious events leading to emergency department or hospital admissions during the first 2 years following the diagnosis of AIN in children.

methodsWe performed a retrospective, multicentre analysis of medical records from 21 French university hospitals of patients aged under 18 years diagnosed with AIN with positive antineutrophils autoantibodies. We collected data on emergency room visits and hospitalisations in the 2 years following diagnosis, causes of these events, microbiology results, management and outcome.

resultsOne hundred and sixty-eight patients were enrolled. Median age at diagnosis of AIN was 13 months. AIN was predominantly diagnosed during an infectious episode (n=120, 71%). In the 2 years of follow-up after diagnosis, 248 events of emergency room visits and/or hospitalisations were reported (0.77 per patient-year). The most frequent diagnoses were common childhood viral or bacterial infections. The incidence rate of severe infections was 0.003 per patient-year. Despite the predominance of viral infections, 177 episodes (71%) led to hospitalisation and 166 (68%) to the initiation of antibiotic therapy, for a median duration of 7 days (IQR 3-10).

conclusionThe risk of severe infections in children with AIN is low. During follow-up, we suggest being attentive to signs of severity during fever, particularly in children over 3 years of age and/or with other immunological comorbidities but not proposing systematic hospitalisation or additional antibiotic therapy.

Indexed as

Autoimmune DiseasesNeutropeniaAdolescentBacterial InfectionsChildChild, PreschoolEmergency Room VisitsEmergency Service, HospitalFemaleFranceHospitalizationHumansIncidenceInfantMaleRetrospective Studiesallergy and immunologyinfectious disease medicine

Identifiers

PMID41535092
PMCPMC13217094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.